1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1327632&form=6&db=m Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. causal interaction,ongoing research,unassigned 4,1,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3023598&form=6&db=m Spironolactone-reversible rickets associated with 11 beta-hydroxysteroid dehydrogenase deficiency syndrome. causal interaction,diagnostic usage,unassigned 4,2,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3860318&form=6&db=m Congenital 11 beta-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,2,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6362571&form=6&db=m Fatal, low renin hypertension associated with a disturbance of cortisol metabolism. causal interaction,unassigned 4,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7554322&form=6&db=m Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess. causal interaction,therapeutic application,unassigned 4,1,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7743156&form=6&db=m Cellular selectivity of aldosterone action: role of 11 beta-hydroxysteroid dehydrogenase. causal interaction,unassigned 2,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7757658&form=6&db=m [11 beta-Hydroxysteroid dehydrogenase deficiency] causal interaction,unassigned 4,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7777721&form=6&db=m Endocrine causes of hypertension. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8445034&form=6&db=m 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,1,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8522281&form=6&db=m Heterogeneity of urinary steroid profiles in children with adrenocortical tumors. therapeutic application,unassigned 1,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8729536&form=6&db=m Apparent mineralocorticoid excess due to 11 beta-hydroxysteroid dehydrogenase deficiency: a possible cause of intrauterine growth retardation. causal interaction,diagnostic usage,unassigned 4,4,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9300202&form=6&db=m Abnormalities of aldosterone synthesis and action in children. causal interaction,unassigned 4,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11028423&form=6&db=m [11 beta-Hydroxysteroid dehydrogenase deficiency] causal interaction,unassigned 4,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14981055&form=6&db=m Impaired 11-beta hydroxysteroid dehydrogenase type 2 activity in sweat gland ducts in human essential hypertension. causal interaction,ongoing research,therapeutic application,unassigned 4,1,4,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (nad+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18407194&form=6&db=m Renin-Independent hypermineralocorticoidism. causal interaction,diagnostic usage,unassigned 4,4,0 1.1.1.B40 11beta-hydroxysteroid dehydrogenase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8370690&form=6&db=m Defects in the HSD11 gene encoding 11 beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. causal interaction,unassigned 4,0 1.1.1.B40 3alpha(or 20beta)-hydroxysteroid dehydrogenase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11150889&form=6&db=m Apparent cortisone reductase deficiency: a rare cause of hyperandrogenemia and hypercortisolism. causal interaction,therapeutic application,unassigned 4,1,0 1.1.1.B40 ACTH Syndrome, Ectopic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1337504&form=6&db=m Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. therapeutic application,unassigned 1,0 1.1.1.B40 ACTH Syndrome, Ectopic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9657070&form=6&db=m Regulation of the 11 beta-hydroxysteroid dehydrogenase in the rat adrenal. Decrease enzymatic activity induced by ACTH. causal interaction,unassigned 3,0 1.1.1.B40 Adenoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11288760&form=6&db=m Cortisol-secreting adrenal adenomas express 11beta-hydroxysteroid dehydrogenase type-2 gene yet possess low 11beta-HSD2 activity. diagnostic usage,ongoing research,therapeutic application,unassigned 3,4,1,0 1.1.1.B40 Adenoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12574226&form=6&db=m Role of local 11 beta-hydroxysteroid dehydrogenase type 2 expression in determining the phenotype of adrenal adenomas. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,2,0 1.1.1.B40 Adrenal Hyperplasia, Congenital http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9516061&form=6&db=m Effect of hypercortisolism and ACTH on the metabolism of cortisol. causal interaction,unassigned 4,0 1.1.1.B40 Adrenal Hyperplasia, Congenital http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10232050&form=6&db=m Hyper- and hypoaldosteronism. causal interaction,therapeutic application,unassigned 4,1,0 1.1.1.B40 Adrenal Hyperplasia, Congenital http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18407194&form=6&db=m Renin-Independent hypermineralocorticoidism. causal interaction,diagnostic usage,unassigned 4,4,0 1.1.1.B40 Alkalosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9657070&form=6&db=m Regulation of the 11 beta-hydroxysteroid dehydrogenase in the rat adrenal. Decrease enzymatic activity induced by ACTH. causal interaction,unassigned 3,0 1.1.1.B40 Alkalosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9661590&form=6&db=m Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. causal interaction,unassigned 3,0 1.1.1.B40 Asthma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8051615&form=6&db=m A novel 11 beta-hydroxysteroid dehydrogenase inhibitor contained in saiboku-to, a herbal remedy for steroid-dependent bronchial asthma. unassigned - 1.1.1.B40 Asthma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11082125&form=6&db=m Magnolol stimulates steroidogenesis in rat adrenal cells. unassigned - 1.1.1.B40 beta-carotene 3-hydroxylase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10232050&form=6&db=m Hyper- and hypoaldosteronism. causal interaction,therapeutic application,unassigned 4,1,0 1.1.1.B40 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9390020&form=6&db=m Inhibition of 11 beta-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticosteroids on MCF-7 and ZR-75-1 breast cancer cells. ongoing research,unassigned 4,0 1.1.1.B40 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8522281&form=6&db=m Heterogeneity of urinary steroid profiles in children with adrenocortical tumors. therapeutic application,unassigned 1,0 1.1.1.B40 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10769675&form=6&db=m Expression of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor in primary lung carcinomas. causal interaction,diagnostic usage,ongoing research,unassigned 2,4,4,0 1.1.1.B40 Cardiomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12586788&form=6&db=m Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation. ongoing research,therapeutic application,unassigned 1,4,0 1.1.1.B40 Cholestasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11696574&form=6&db=m Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis. therapeutic application,unassigned 1,0 1.1.1.B40 Choriocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8782085&form=6&db=m Regulation of 11 beta-hydroxysteroid dehydrogenase type 2 activity and mRNA in human choriocarcinoma cells. ongoing research,unassigned 4,0 1.1.1.B40 Choriocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8865170&form=6&db=m Analysis of the promoter of the NAD+ dependent 11 beta-hydroxysteroid dehydrogenase (HSD11K) gene in JEG-3 human choriocarcinoma cells. ongoing research,unassigned 3,0 1.1.1.B40 Cushing Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7777721&form=6&db=m Endocrine causes of hypertension. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 1.1.1.B40 Cushing Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8530609&form=6&db=m 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. causal interaction,therapeutic application,unassigned 3,2,0 1.1.1.B40 Cushing Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8616526&form=6&db=m Human kidney 11 beta-hydroxysteroid dehydrogenase: regulation by adrenocorticotropin? causal interaction,unassigned 3,0 1.1.1.B40 Cushing Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10965482&form=6&db=m [Decreased activity of 11-beta-hydroxysteroid dehydrogenase in patients with Cushing's syndrome] causal interaction,diagnostic usage,ongoing research,unassigned 1,3,3,0 1.1.1.B40 Cushing Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11576621&form=6&db=m Effect of glucocorticoid excess on the cortisol/cortisone ratio. causal interaction,unassigned 3,0 1.1.1.B40 Cushing Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18407194&form=6&db=m Renin-Independent hypermineralocorticoidism. causal interaction,diagnostic usage,unassigned 4,4,0 1.1.1.B40 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21114371&form=6&db=m Evaluation of hepatic 11 beta-hydroxysteroid dehydrogenase activity by cortisone acetate test in young adults with diabetes mellitus type 1. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 1.1.1.B40 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12519867&form=6&db=m Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. ongoing research,therapeutic application,unassigned 4,1,0 1.1.1.B40 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17030965&form=6&db=m Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. causal interaction,ongoing research,unassigned 2,3,0 1.1.1.B40 Eczema http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1970371&form=6&db=m Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. diagnostic usage,ongoing research,unassigned 1,4,0 1.1.1.B40 Endocrine System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7777721&form=6&db=m Endocrine causes of hypertension. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 1.1.1.B40 Endometrial Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11604236&form=6&db=m Modulation of 11 beta-hydroxysteroid dehydrogenase type 2 activity in Ishikawa cells is associated with changes in cellular proliferation. ongoing research,unassigned 4,0 1.1.1.B40 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7701542&form=6&db=m The activities of 5 beta-reductase and 11 beta-hydroxysteroid dehydrogenase in essential hypertension. diagnostic usage,unassigned 1,0 1.1.1.B40 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7843756&form=6&db=m Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension. causal interaction,unassigned 1,0 1.1.1.B40 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8191553&form=6&db=m Organ-specific actions of 11 beta-hydroxysteroid dehydrogenase in humans: implications for the pathophysiology of hypertension. causal interaction,therapeutic application,unassigned 3,1,0 1.1.1.B40 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8331819&form=6&db=m [Endocrine hypertension] causal interaction,unassigned 4,0 1.1.1.B40 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8370136&form=6&db=m Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension. causal interaction,unassigned 3,0 1.1.1.B40 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8567041&form=6&db=m Endogenous renal 11 beta-hydroxysteroid dehydrogenase inhibitory factors in patients with low-renin essential hypertension. causal interaction,unassigned 3,0 1.1.1.B40 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8713673&form=6&db=m Corticosteroids in essential hypertension: multiple candidate loci and phenotypic variation. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,1,0 1.1.1.B40 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8794836&form=6&db=m Genetic association of 11 beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks. causal interaction,unassigned 4,0 1.1.1.B40 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14981055&form=6&db=m Impaired 11-beta hydroxysteroid dehydrogenase type 2 activity in sweat gland ducts in human essential hypertension. causal interaction,ongoing research,therapeutic application,unassigned 4,1,4,0 1.1.1.B40 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19882252&form=6&db=m 11beta-hydroxysteroid dehydrogenase type-2 and type-1 (11beta-HSD2 and 11beta-HSD1) and 5beta-reductase activities in the pathogenia of essential hypertension. unassigned - 1.1.1.B40 Fetal Growth Retardation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8729536&form=6&db=m Apparent mineralocorticoid excess due to 11 beta-hydroxysteroid dehydrogenase deficiency: a possible cause of intrauterine growth retardation. causal interaction,diagnostic usage,unassigned 4,4,0 1.1.1.B40 Genetic Diseases, Inborn http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9661590&form=6&db=m Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. causal interaction,unassigned 3,0 1.1.1.B40 Genetic Diseases, Inborn http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26892095&form=6&db=m Apparent mineralocorticoid excess and the long term treatment of genetic hypertension. causal interaction,therapeutic application,unassigned 4,1,0 1.1.1.B40 Heart Failure http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8291900&form=6&db=m Inhibitors of 11 beta-hydroxysteroid dehydrogenase and 5 beta-steroid reductase in urine from patients with congestive heart failure. therapeutic application,unassigned 1,0 1.1.1.B40 Heart Failure http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32564866&form=6&db=m Glucocorticoid metabolism and the action of 11 beta-hydroxysteroid dehydrogenase 2 in canine congestive heart failure. therapeutic application,unassigned 1,0 1.1.1.B40 Hyperaldosteronism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7777721&form=6&db=m Endocrine causes of hypertension. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 1.1.1.B40 Hyperaldosteronism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8232712&form=6&db=m [Hypokalemia without arterial hypertension by licorice poisoning] causal interaction,therapeutic application,unassigned 1,1,0 1.1.1.B40 Hyperandrogenism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8289851&form=6&db=m Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase. causal interaction,unassigned 3,0 1.1.1.B40 Hyperandrogenism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12364451&form=6&db=m 5 alpha-reductase and 11 beta-hydroxysteroid dehydrogenase activity in prepubertal Hispanic girls with premature adrenarche. diagnostic usage,ongoing research,unassigned 1,4,0 1.1.1.B40 Hyperglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16891583&form=6&db=m Glucocorticoid "programming" and PTSD risk. causal interaction,ongoing research,unassigned 2,1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1327632&form=6&db=m Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. causal interaction,ongoing research,unassigned 4,1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1879383&form=6&db=m Defects in cortisol metabolism causing low-renin hypertension. causal interaction,ongoing research,unassigned 4,2,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2316675&form=6&db=m The 11 beta-OHSD inhibitor, carbenoxolone, enhances Na retention by aldosterone and 11-deoxycorticosterone. therapeutic application,unassigned 1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2508491&form=6&db=m Effect of carbenoxolone on glucocorticoid metabolism and Na transport in toad bladder. causal interaction,therapeutic application,unassigned 3,1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3860318&form=6&db=m Congenital 11 beta-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,2,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7554322&form=6&db=m Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess. causal interaction,therapeutic application,unassigned 4,1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7662229&form=6&db=m Cortisol metabolism in hypertensive patients who do and do not develop hypokalemia from diuretics. causal interaction,unassigned 4,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7670488&form=6&db=m Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. causal interaction,unassigned 4,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7777721&form=6&db=m Endocrine causes of hypertension. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7843756&form=6&db=m Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension. causal interaction,unassigned 1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7852515&form=6&db=m Endogenous inhibitors of 11 beta-hydroxysteroid dehydrogenase in hypertension. causal interaction,therapeutic application,unassigned 3,4,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7920454&form=6&db=m Haemodynamic and metabolic effects of carbenoxolone in normal subjects and patients with renal impairment. causal interaction,unassigned 4,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8146578&form=6&db=m [Aldosterone and 11 beta-hydroxysteroid dehydrogenase: role in arterial hypertension] causal interaction,ongoing research,unassigned 4,3,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8190006&form=6&db=m Decreased activity of 11 beta-hydroxysteroid dehydrogenase in mesenteric arteries of Dahl salt-sensitive rats. diagnostic usage,unassigned 1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8191553&form=6&db=m Organ-specific actions of 11 beta-hydroxysteroid dehydrogenase in humans: implications for the pathophysiology of hypertension. causal interaction,therapeutic application,unassigned 3,1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8232712&form=6&db=m [Hypokalemia without arterial hypertension by licorice poisoning] causal interaction,therapeutic application,unassigned 1,1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8370690&form=6&db=m Defects in the HSD11 gene encoding 11 beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. causal interaction,unassigned 4,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8381253&form=6&db=m 11 beta-Hydroxysteroid dehydrogenase activity in hypertension and renal disease. diagnostic usage,ongoing research,unassigned 3,3,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8393954&form=6&db=m Investigation of the mechanism of hypertension in apparent mineralocorticoid excess. causal interaction,unassigned 4,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8530609&form=6&db=m 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. causal interaction,therapeutic application,unassigned 3,2,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8538347&form=6&db=m Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. causal interaction,unassigned 4,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8547169&form=6&db=m Placental 11 beta-hydroxysteroid dehydrogenase and the programming of hypertension. causal interaction,therapeutic application,unassigned 3,1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8564448&form=6&db=m Corticosteroid hypertension. causal interaction,unassigned 1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8713674&form=6&db=m Sodium status, corticosteroid metabolism and blood pressure in normal human subjects and in a patient with abnormal salt appetite. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,2,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8810740&form=6&db=m 11 beta-Hydroxysteroid dehydrogenase deficit: a rare cause of arterial Hypertension. Diagnosis and therapeutic approach in two young brothers. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8969942&form=6&db=m Endogenous 11 beta-hydroxysteroid dehydrogenase inhibitors and their role in glucocorticoid Na+ retention and hypertension. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8977758&form=6&db=m Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. diagnostic usage,unassigned 1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8979285&form=6&db=m 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. causal interaction,unassigned 1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9029720&form=6&db=m Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. causal interaction,unassigned 1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9120678&form=6&db=m Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess. causal interaction,unassigned 2,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9247735&form=6&db=m Mutations in the 11 beta-hydroxysteroid dehydrogenase type II enzyme associated with hypertension and possibly stillbirth. causal interaction,unassigned 4,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9398712&form=6&db=m A new compound heterozygous mutation in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess. causal interaction,unassigned 4,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9597634&form=6&db=m Cortisol, hypertension and obesity: the role of 11 beta-hydroxysteroid dehydrogenase. causal interaction,ongoing research,unassigned 3,1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9657070&form=6&db=m Regulation of the 11 beta-hydroxysteroid dehydrogenase in the rat adrenal. Decrease enzymatic activity induced by ACTH. causal interaction,unassigned 3,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9661590&form=6&db=m Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. causal interaction,unassigned 3,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9683905&form=6&db=m The role of 11 beta-hydroxysteroid dehydrogenase in the pathogenesis of hypertension. causal interaction,unassigned 4,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9800281&form=6&db=m Placental 11 beta-hydroxysteroid dehydrogenase activity in normotensive and pre-eclamptic pregnancies. causal interaction,unassigned 3,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10824333&form=6&db=m 11 beta-Hydroxysteroid dehydrogenase: a link between the dysregulation of cortisol metabolism and hypertension. causal interaction,unassigned 2,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11114699&form=6&db=m Association between a variant in the 11 beta-hydroxysteroid dehydrogenase type 2 gene and primary hypertension. causal interaction,unassigned 4,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11234613&form=6&db=m 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD-II) activity in human placenta: its relationship to placental weight and birth weight and its possible role in hypertension. ongoing research,unassigned 4,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11416003&form=6&db=m The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. causal interaction,ongoing research,unassigned 2,2,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12587501&form=6&db=m [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension] causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,2,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15718388&form=6&db=m Interactions between 11beta-hydroxysteroid dehydrogenase and COX-2 in kidney. causal interaction,ongoing research,unassigned 4,4,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16891583&form=6&db=m Glucocorticoid "programming" and PTSD risk. causal interaction,ongoing research,unassigned 2,1,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18178212&form=6&db=m Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,1 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20427719&form=6&db=m Fetal growth restriction alters transcription factor binding and epigenetic mechanisms of renal 11{beta}-hydroxysteroid dehydrogenase type 2 in a sex-specific manner. ongoing research,unassigned 2,0 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25133511&form=6&db=m Insulin, CCAAT/enhancer-binding proteins and lactate regulate the human 11?-hydroxysteroid dehydrogenase type 2 gene expression in colon cancer cell lines. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,4,1 1.1.1.B40 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26892095&form=6&db=m Apparent mineralocorticoid excess and the long term treatment of genetic hypertension. causal interaction,therapeutic application,unassigned 4,1,0 1.1.1.B40 Hypoaldosteronism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9661590&form=6&db=m Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. causal interaction,unassigned 3,0 1.1.1.B40 Hypoaldosteronism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26892095&form=6&db=m Apparent mineralocorticoid excess and the long term treatment of genetic hypertension. causal interaction,therapeutic application,unassigned 4,1,0 1.1.1.B40 Hypokalemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7662229&form=6&db=m Cortisol metabolism in hypertensive patients who do and do not develop hypokalemia from diuretics. causal interaction,unassigned 4,0 1.1.1.B40 Hypokalemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8003443&form=6&db=m Inhibition of 11 beta-hydroxysteroid dehydrogenase obtained from guinea pig kidney by furosemide, naringenin and some other compounds. causal interaction,therapeutic application,unassigned 2,2,0 1.1.1.B40 Hypokalemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9398712&form=6&db=m A new compound heterozygous mutation in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess. causal interaction,unassigned 4,0 1.1.1.B40 Hypokalemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26892095&form=6&db=m Apparent mineralocorticoid excess and the long term treatment of genetic hypertension. causal interaction,therapeutic application,unassigned 4,1,0 1.1.1.B40 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9043952&form=6&db=m Active catabolism of glucocorticoids by 11 beta-hydroxysteroid dehydrogenase in vivo is a necessary requirement for natural resistance to infection with Listeria monocytogenes. therapeutic application,unassigned 1,0 1.1.1.B40 Infertility http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10086068&form=6&db=m 11 beta-Hydroxysteroid dehydrogenase enzyme activity in granulosa cells derived from ovarian follicles of in vitro fertilization patients. ongoing research,unassigned 4,0 1.1.1.B40 Inflammatory Bowel Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28932959&form=6&db=m The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease. causal interaction,unassigned 4,0 1.1.1.B40 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12397528&form=6&db=m The metabolic syndrome X and peripheral cortisol synthesis. causal interaction,unassigned 3,0 1.1.1.B40 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12519867&form=6&db=m Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. ongoing research,therapeutic application,unassigned 4,1,0 1.1.1.B40 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16041833&form=6&db=m The polygenetically inherited metabolic syndrome of WOKW rats is associated with insulin resistance and altered gene expression in adipose tissue. ongoing research,therapeutic application,unassigned 3,1,0 1.1.1.B40 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19186324&form=6&db=m Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects. ongoing research,therapeutic application,unassigned 1,1,0 1.1.1.B40 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18084163&form=6&db=m Meeting Report:The 7th ESPE Growth Plate Working Group Symposium - EUROGROP June 27th 2007, Helsinki, Finland. causal interaction,ongoing research,unassigned 1,1,0 1.1.1.B40 Liddle Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18362159&form=6&db=m Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury. causal interaction,unassigned 3,0 1.1.1.B40 Liver Cirrhosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9428231&form=6&db=m Down-regulation of hepatic and renal 11 beta-hydroxysteroid dehydrogenase in rats with liver cirrhosis. causal interaction,ongoing research,unassigned 1,3,0 1.1.1.B40 Liver Cirrhosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16192424&form=6&db=m Increased apical targeting of renal epithelial sodium channel subunits and decreased expression of type 2 11beta-hydroxysteroid dehydrogenase in rats with CCl4-induced decompensated liver cirrhosis. unassigned - 1.1.1.B40 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8445034&form=6&db=m 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,1,0 1.1.1.B40 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15206142&form=6&db=m [Novel transgenic mouse model of the metabolic syndrome] causal interaction,unassigned 4,0 1.1.1.B40 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17368420&form=6&db=m [11beta-hydroxysteroide dehydrogenases. Recent advances] causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,4,0 1.1.1.B40 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32357081&form=6&db=m Global 11 Beta-Hydroxysteroid Dehydrogenase Activity Assessed by the Circulating Cortisol to Cortisone Ratio is Associated with Features of Metabolic Syndrome. causal interaction,diagnostic usage,unassigned 3,1,0 1.1.1.B40 Mineralocorticoid Excess Syndrome, Apparent http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1476186&form=6&db=m Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone. causal interaction,unassigned 1,0 1.1.1.B40 Mineralocorticoid Excess Syndrome, Apparent http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22487411&form=6&db=m [Liquorice-induced hypertension and hypokalaemia]. ongoing research,unassigned 1,0 1.1.1.B40 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8234066&form=6&db=m Presence of 11 beta-hydroxysteroid dehydrogenase enzyme in the human prostate tumor cell line LNCaP. diagnostic usage,ongoing research,unassigned 4,4,0 1.1.1.B40 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9858912&form=6&db=m 11 beta-hydroxysteroid dehydrogenase type II in human colon: a new marker of fetal development and differentiation in neoplasms. ongoing research,unassigned 3,0 1.1.1.B40 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17030965&form=6&db=m Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. causal interaction,ongoing research,unassigned 2,3,0 1.1.1.B40 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18407194&form=6&db=m Renin-Independent hypermineralocorticoidism. causal interaction,diagnostic usage,unassigned 4,4,0 1.1.1.B40 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28386270&form=6&db=m Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPAR? Regulation in Hyperlipidemic and Hypertensive Conditions. ongoing research,unassigned 2,0 1.1.1.B40 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8289851&form=6&db=m Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase. causal interaction,unassigned 3,0 1.1.1.B40 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9597634&form=6&db=m Cortisol, hypertension and obesity: the role of 11 beta-hydroxysteroid dehydrogenase. causal interaction,ongoing research,unassigned 3,1,0 1.1.1.B40 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12519880&form=6&db=m 11 beta-Hydroxysteroid dehydrogenase activity in hypothalamic obesity. unassigned - 1.1.1.B40 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17030965&form=6&db=m Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. causal interaction,ongoing research,unassigned 2,3,0 1.1.1.B40 Obesity, Abdominal http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11196447&form=6&db=m The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis. causal interaction,ongoing research,unassigned 1,2,0 1.1.1.B40 Obesity, Abdominal http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15047607&form=6&db=m Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. causal interaction,ongoing research,therapeutic application,unassigned 3,2,2,0 1.1.1.B40 Obesity, Abdominal http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19567539&form=6&db=m Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women. causal interaction,diagnostic usage,ongoing research,unassigned 3,1,1,0 1.1.1.B40 Osteoporosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11196447&form=6&db=m The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis. causal interaction,ongoing research,unassigned 1,2,0 1.1.1.B40 Osteosarcoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10333548&form=6&db=m Characterization of 11beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,4,0 1.1.1.B40 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17028049&form=6&db=m Type 2 11beta-hydroxysteroid dehydrogenase activity in human ovarian cancer. diagnostic usage,ongoing research,unassigned 4,4,0 1.1.1.B40 Pheochromocytoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7777721&form=6&db=m Endocrine causes of hypertension. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 1.1.1.B40 Pituitary Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11397878&form=6&db=m Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors. causal interaction,ongoing research,unassigned 4,3,0 1.1.1.B40 Pituitary Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12642869&form=6&db=m Abnormal expression of 11 beta-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation. causal interaction,ongoing research,unassigned 4,1,0 1.1.1.B40 Polycystic Ovary Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8289851&form=6&db=m Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase. causal interaction,unassigned 3,0 1.1.1.B40 Polycystic Ovary Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12364451&form=6&db=m 5 alpha-reductase and 11 beta-hydroxysteroid dehydrogenase activity in prepubertal Hispanic girls with premature adrenarche. diagnostic usage,ongoing research,unassigned 1,4,0 1.1.1.B40 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7721407&form=6&db=m 11 beta-Hydroxysteroid dehydrogenase and its inhibitors in hypertensive pregnancy. diagnostic usage,ongoing research,unassigned 3,2,0 1.1.1.B40 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8031714&form=6&db=m 11 beta-Hydroxysteroid dehydrogenase and tissue specificity of androgen action in human prostate cancer cell LNCaP. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,4,1 1.1.1.B40 Psoriasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1970371&form=6&db=m Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. diagnostic usage,ongoing research,unassigned 1,4,0 1.1.1.B40 Respiratory Distress Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14629298&form=6&db=m Increased expression of 11 beta-hydroxysteroid dehydrogenase type 2 in the lungs of patients with acute respiratory distress syndrome. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,4,0 1.1.1.B40 Rickets http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3023598&form=6&db=m Spironolactone-reversible rickets associated with 11 beta-hydroxysteroid dehydrogenase deficiency syndrome. causal interaction,diagnostic usage,unassigned 4,2,0 1.1.1.B40 Stillbirth http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9247735&form=6&db=m Mutations in the 11 beta-hydroxysteroid dehydrogenase type II enzyme associated with hypertension and possibly stillbirth. causal interaction,unassigned 4,0 1.1.1.B40 Vaccinia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2082184&form=6&db=m Expression of 11 beta-hydroxysteroid dehydrogenase using recombinant vaccinia virus. diagnostic usage,ongoing research,unassigned 3,3,0